MedTrace Logo

5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris

NCT00714454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2008-07-14

No results posted yet for this study

Summary

12-week study to compare the efficacy and safety of a course of a twice daily treatment with APS in the form of a lotion to its vehicle for the treatment of acne.

Conditions

  • Acne Vulgaris

Interventions

OTHER

APS Topical Lotion

OTHER

Placebo

Sponsors & Collaborators

  • Ikeno Clinic

    collaborator UNKNOWN

  • University of Miami

    lead OTHER

Principal Investigators

  • Heather Woolery-Lloyd, MD · University of Miami

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00714454 on ClinicalTrials.gov